Opportunities for Bioinformatics in European Drug Discovery Market : Market Research Report

Opportunities for Bioinformatics in European Drug Discovery Market

Published: Apr. 25, 2007

1. Executive Summary: 1. Summary of Findings
2. Glossary: 1. Glossary of Terms
3. Research Methodology: 1. Methodology Adopted
4. Overview of Challenges Faced by the Bioinformatics Industry: 1. Challenges Faced by the Bioinformatics Industry
5. European Bioinformatics Market: 1. Market Overview; 2. Segmentation; 3. Market Drivers; 4. Market Restraints; 5. Revenue Forecasts; 6. Geographical Trends; 7. Competitive Analysis; 8. Company Profiling
6. Genomic Market: 1. Genomic Market in Europe
7. Proteomics Market: 1. Proteomics Market in Europe
8. Information Manipulation Market: 1. Information Manipulation Market in Europe
9. Geographic Trends: 1. European Bioinformatics Market; 2. UK Bioinformatics Market; 3. German Bioinformatics Market; 4. French Bioinformatics Market; 5. Scandinavian Bioinformatics Market; 6. Benelux Bioinformatics Market
10. Strategic Recommendations: 1. Recommendations
11. Database of Key Industry Participants: 1. Key Industry Participants
12. Appendix: 1. Decision Support Database
List of Figures
Chapter 4: Opportunities for Bioinformatics in European Drug Discovery Market: Market Challenges Ranked in Order of Impact (Europe), 2006-2013
Chapter 5: Traditional Method of Drug Discovery; Modern Method of Drug discovery; Market Segmentation of European Bioinformatics Market; Opportunities for Bioinformatics in European drug Discovery Market: Market Drivers Ranked in Order of Impact (Europe), 2006-2013; Opportunities for Bioinformatics in European Drug Discovery Market: Market Restraints Ranked in Order of Impact (Europe), 2006-2013; Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts (Europe), 2006-2013; Opportunities for Bioinformatics in European drug Discovery Market: Competitive Structure (Region), 2006
Chapter 6: Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Genomic Segment (Europe), 2006-2013
Chapter 7: Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Proteomic Segment (Europe), 2006-2013
Chapter 8: Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Information Manipulation Segment (Europe), 2006-2013
Chapter 9: Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (United Kingdom), 2006-2013; Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Germany), 2006-2013; Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (France), 2006-2013; Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Scandinavia), 2006-2013; Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Benelux), 2006-2013

Abstract

This Frost & Sullivan research service titled Opportunities for Bioinformatics in European Drug Discovery Market provides a detailed analysis of the key factors driving growth in the European bioinformatics industry in the drug discovery market. The study also covers the basic aspects of bioinformatics including the segmentation pattern and the challenges faced by market participants. In this research, Frost & Sullivan’s expert analysts thoroughly examine the following applications: proteomic applications, genomic applications and bioinformatics manipulation systems.

Market Overview

Growing Demand for Advanced Data Handling Tools Promotes Need for Bioinformatics in the European Drug Discovery Market

The European bioinformatics industry is competing in a growing market, dominated by a few large vendors. Bioinformatics has varied applications in the drug discovery market, including proteomic, genomic and information manipulation applications. Most of the life sciences organisations involved in the process of drug discovery adopt bioinformatics in varying degrees in their routine process.

The growth rates in the bioinformatics market are modest, yet steady. The large amount of data generated in the process of drug discovery is creating increasing demand for improved data handling tools. "It is impossible for professionals to handle and analyse the data without the use of advanced computational tools," notes the analyst of this research service. "Here, bioinformatics has been able to constantly develop new tools that are capable of handling high-end voluminous data, thereby facilitating the work of life sciences professionals." Moreover, given the reducing drug pipelines in the European pharmaceuticals industry, companies are looking for tools to increase drug research productivity. This demand from pharmaceuticals and life science companies is another factor influencing the bioinformatics market favourably.

Emphasis on Continuous Training and Support for Life Science Professionals Essential

A key factor restraining market growth is the resistance of European companies in adopting new technologies. "Undoubtedly, bioinformatics offers the best forms of application to life sciences companies for the simplification of the drug discovery process," remarks the analyst. "However, the conservative attitude of European companies toward the adoption of new technologies is a well-known fact." In addition to this, as various companies use different data formats, proprietary and incompatible data formats limit the value of bioinformatics.

Yet another challenge that exists in the market is that the tools presently used in the European bioinformatics industry mostly serve specialised end users. As these tools require a technical skill set, researches who are directly involved in the R&D process do not get to use the bioinformatics tools. As a result, all professionals who utilise the tools will need to be periodically trained in the functioning of the tools to enable them to take full advantage of the functionality. Thus, continuous training and support for life science professionals will help drive market growth. Market participants should also look to acquire or form alliances with companies that can help them broaden their product portfolio, rather than increase their market share. By expanding their product portfolio, smaller companies can hope to actively compete with the larger multi-modality vendors.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

advertise with us

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Opportunities for Bioinformatics in European Drug Discovery Market

Table of Contents

Abstract